Orbis Gains 5%

Orbis Investment Management Limited announced on 12 June 2026 that it now controls 3,112,476 voting shares in Genmab A/S, representing 4.99 % of the company’s share capital. The notification, filed under Section 30 of the Danish Capital Markets Act, is likely to influence investor sentiment and market perception but does not alter Genmab’s operations, finances or pipeline.